These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 31601026)
1. A Smo/Gli Multitarget Hedgehog Pathway Inhibitor Impairs Tumor Growth. Lospinoso Severini L; Quaglio D; Basili I; Ghirga F; Bufalieri F; Caimano M; Balducci S; Moretti M; Romeo I; Loricchio E; Maroder M; Botta B; Mori M; Infante P; Di Marcotullio L Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31601026 [No Abstract] [Full Text] [Related]
2. Synergistic inhibition of the Hedgehog pathway by newly designed Smo and Gli antagonists bearing the isoflavone scaffold. Berardozzi S; Bernardi F; Infante P; Ingallina C; Toscano S; De Paolis E; Alfonsi R; Caimano M; Botta B; Mori M; Di Marcotullio L; Ghirga F Eur J Med Chem; 2018 Aug; 156():554-562. PubMed ID: 30025349 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of WO2014207069 A1: Multitarget Hedgehog pathway inhibitors and uses thereof. Manetti F; Petricci E Expert Opin Ther Pat; 2016; 26(4):529-35. PubMed ID: 26666870 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of Hedgehog Signaling in Fibroblasts, Pancreatic, and Lung Tumor Cells by Oxy186, an Oxysterol Analogue with Drug-Like Properties. Wang F; Stappenbeck F; Parhami F Cells; 2019 May; 8(5):. PubMed ID: 31137846 [TBL] [Abstract][Full Text] [Related]
5. Casein Kinase 1D Encodes a Novel Drug Target in Hedgehog-GLI-Driven Cancers and Tumor-Initiating Cells Resistant to SMO Inhibition. Peer E; Aichberger SK; Vilotic F; Gruber W; Parigger T; Grund-Gröschke S; Elmer DP; Rathje F; Ramspacher A; Zaja M; Michel S; Hamm S; Aberger F Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439381 [TBL] [Abstract][Full Text] [Related]
6. The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury. Grzelak CA; Martelotto LG; Sigglekow ND; Patkunanathan B; Ajami K; Calabro SR; Dwyer BJ; Tirnitz-Parker JE; Watkins DN; Warner FJ; Shackel NA; McCaughan GW J Hepatol; 2014 Jan; 60(1):143-51. PubMed ID: 23978713 [TBL] [Abstract][Full Text] [Related]
7. ABT-737 suppresses aberrant Hedgehog pathway and overcomes resistance to smoothened antagonists by blocking Gli. Huang W; Liu H; Tan W; Wang J Med Oncol; 2022 Sep; 39(12):188. PubMed ID: 36071246 [TBL] [Abstract][Full Text] [Related]
8. Targeting GLI factors to inhibit the Hedgehog pathway. Infante P; Alfonsi R; Botta B; Mori M; Di Marcotullio L Trends Pharmacol Sci; 2015 Aug; 36(8):547-58. PubMed ID: 26072120 [TBL] [Abstract][Full Text] [Related]
9. Next-Generation Hedgehog/GLI Pathway Inhibitors for Cancer Therapy. Peer E; Tesanovic S; Aberger F Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30991683 [TBL] [Abstract][Full Text] [Related]
10. Current trends in Hedgehog signaling pathway inhibition by small molecules. Ghirga F; Mori M; Infante P Bioorg Med Chem Lett; 2018 Oct; 28(19):3131-3140. PubMed ID: 30177379 [TBL] [Abstract][Full Text] [Related]
11. Novel-smoothened inhibitors for therapeutic targeting of naïve and drug-resistant hedgehog pathway-driven cancers. Li QR; Zhao H; Zhang XS; Lang H; Yu K Acta Pharmacol Sin; 2019 Feb; 40(2):257-267. PubMed ID: 29777201 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of Pancreatic Cancer Cell-Induced Paracrine Hedgehog Signaling by Liver X Receptor Agonists and Oxy16, a Naturally Occurring Oxysterol. Wang F; Stappenbeck F; Matsui W; Parhami F J Cell Biochem; 2017 Mar; 118(3):499-509. PubMed ID: 27490478 [TBL] [Abstract][Full Text] [Related]
13. Hedgehog signaling pathway inhibitors: an updated patent review (2015-present). Quaglio D; Infante P; Di Marcotullio L; Botta B; Mori M Expert Opin Ther Pat; 2020 Apr; 30(4):235-250. PubMed ID: 32070165 [No Abstract] [Full Text] [Related]
14. β-arrestin1-mediated acetylation of Gli1 regulates Hedgehog/Gli signaling and modulates self-renewal of SHH medulloblastoma cancer stem cells. Miele E; Po A; Begalli F; Antonucci L; Mastronuzzi A; Marras CE; Carai A; Cucchi D; Abballe L; Besharat ZM; Catanzaro G; Infante P; Di Marcotullio L; Canettieri G; De Smaele E; Screpanti I; Locatelli F; Ferretti E BMC Cancer; 2017 Jul; 17(1):488. PubMed ID: 28716052 [TBL] [Abstract][Full Text] [Related]
15. The Role of Smoothened-Dependent and -Independent Hedgehog Signaling Pathway in Tumorigenesis. Chai JY; Sugumar V; Alshawsh MA; Wong WF; Arya A; Chong PP; Looi CY Biomedicines; 2021 Sep; 9(9):. PubMed ID: 34572373 [TBL] [Abstract][Full Text] [Related]
16. The PROTAC selectively degrading Bcl-x Zhang S; Chen Y; Xu Z; Yang J; Sun R; Wang J; Sun Y; Jiang B; Yang X; Tan W Theranostics; 2022; 12(17):7476-7490. PubMed ID: 36438482 [No Abstract] [Full Text] [Related]
17. Activation of hedgehog signaling and its association with cisplatin resistance in ovarian epithelial tumors. Song X; Yan L; Lu C; Zhang C; Zhu F; Yang J; Jing H; Zhang Y; Qiao J; Guo H Oncol Lett; 2018 Apr; 15(4):5569-5576. PubMed ID: 29552194 [TBL] [Abstract][Full Text] [Related]
18. Cynanbungeigenin C and D, a pair of novel epimers from Cynanchum bungei, suppress hedgehog pathway-dependent medulloblastoma by blocking signaling at the level of Gli. Li XY; Zhou LF; Gao LJ; Wei Y; Xu SF; Chen FY; Huang WJ; Tan WF; Ye YP Cancer Lett; 2018 Apr; 420():195-207. PubMed ID: 29425683 [TBL] [Abstract][Full Text] [Related]
19. Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo. Wickström M; Dyberg C; Shimokawa T; Milosevic J; Baryawno N; Fuskevåg OM; Larsson R; Kogner P; Zaphiropoulos PG; Johnsen JI Int J Cancer; 2013 Apr; 132(7):1516-24. PubMed ID: 22949014 [TBL] [Abstract][Full Text] [Related]
20. Targeting the Hedgehog signaling pathway in cancer: beyond Smoothened. Gonnissen A; Isebaert S; Haustermans K Oncotarget; 2015 Jun; 6(16):13899-913. PubMed ID: 26053182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]